New Zealand markets closed

BioLife Solutions, Inc. (BLFS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
24.04+1.01 (+4.39%)
At close: 04:00PM EDT
24.04 0.00 (0.00%)
After hours: 04:46PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-104,049
-66,427
-139,805
-8,908
1,983
-
Depreciation & amortisation
17,782
12,295
16,472
12,865
5,068
-
Deferred income taxes
-7,524
-62
-5,238
-20,127
-3,297
-
Stock-based compensation
22,736
31,670
25,334
13,956
5,981
-
Change in working capital
-16,160
1,467
-14,905
-2,258
-1,097
-
Accounts receivable
-12,430
15,351
-10,753
-10,132
-1,786
-
Inventory
-4,052
-8,552
-6,559
114
-629
-
Accounts payable
-2,965
-8,425
414
2,018
-171
-
Other working capital
-24,622
-18,879
-18,873
-12,978
2,012
-
Other non-cash items
-4
-6,891
-1,084
-1,049
2,562
-
Net cash provided by operating activities
-17,119
-12,498
-8,488
-4,593
6,645
-
Cash flows from investing activities
Investments in property, plant and equipment
-7,503
-6,381
-10,385
-8,385
-4,633
-
Acquisitions, net
-
-
0
0
-15,942
-23,439
Purchases of investments
-35,767
-27,095
-53,116
0
-1,000
-
Sales/maturities of investments
47,718
56,169
8,920
0
0
-
Other investing activities
-3,228
-4,856
-3,536
-6,371
-3,175
-
Net cash used for investing activities
-45,765
17,837
-58,117
-13,192
-24,715
-
Cash flows from financing activities
Debt repayment
-5,213
-498
-2,164
-31,750
-2,175
-
Common stock issued
-
10,244
0
0
100,121
-
Common stock repurchased
-
-
-
-
-
0
Dividends paid
-
-
-
-
-
0
Other financing activities
-1,425
338
-1,843
-1,302
-539
-
Net cash used provided by (used for) financing activities
14,836
10,591
16,316
-2,778
102,078
-
Net change in cash
-48,048
15,930
-50,289
-20,563
84,008
-
Cash at beginning of period
75,151
19,473
69,870
90,456
6,448
-
Cash at end of period
27,103
35,438
19,473
69,870
90,456
-
Free cash flow
Operating cash flow
-17,119
-12,498
-8,488
-4,593
6,645
-
Capital expenditure
-7,503
-6,381
-10,385
-8,385
-4,633
-
Free cash flow
-24,622
-18,879
-18,873
-12,978
2,012
-